Last updated on November 2016

Autologous Cell Therapy for Treatment of Fecal Incontinence


Brief description of study

The aim of this clinical study is to investigate the safety and feasibility of Autologous Muscle Derived Cells (AMDC; a preparation of a patient's own cells) injection into the anal sphincter for treatment of patients with fecal incontinence.

Clinical Study Identifier: NCT01600755

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Manoj J. Raval, MD

St. Paul's Hospital
Vancouver, BC Canada
  Connect »

Charles Knowles, Prof

Royal Hospital of London, National Centre for Bowel Research & Surgical Innovation
London, United Kingdom
  Connect »